Pharmacokinetics and Pharmacodynamics of Phase II Drug Metabolizing/Antioxidant Enzymes Gene Response by Anti-cancer Agent Sulforaphane in Rat Lymphocytes

PURPOSE: This study assesses the pharmacokinetics (PK) and pharmacodynamics (PD) of Nrf2-mediated increased expression of Phase II drug metabolizing enzyme (DME) and antioxidant enzymes which represents an important component of cancer chemoprevention in rat lymphocytes following intravenous (i.v.)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wang, Hu, Khor, Tin Oo, Yang, Qian, Huang, Ying, Wu, Tien-yuan, Saw, Constance Lay-Lay, Lin, Wen, Androulakis, Ioannis P., Kong, Ah-Ng Tony
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3580178/
https://ncbi.nlm.nih.gov/pubmed/22931102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300130k
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares